Cowen Prime Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $4.06M | Sell |
24,500
-460
| -2% | -$74.2K | 1.4% | 16 |
|
|
2023
Q1 | $4.09M | Hold |
24,960
| – | – | 1.64% | 15 |
|
|
2022
Q4 | $4.41M | Buy |
24,960
+7,300
| +41% | +$1.26M | 1.81% | 14 |
|
|
2022
Q3 | $2.88M | Hold |
17,660
| – | – | 1.66% | 13 |
|
|
2022
Q2 | $3.13M | Hold |
17,660
| – | – | 1.78% | 13 |
|
|
2022
Q1 | $3.13M | Hold |
17,660
| – | – | 1.32% | 18 |
|
|
2021
Q4 | $3.02M | Sell |
17,660
-900
| -5% | -$147K | 1.03% | 26 |
|
|
2021
Q3 | $3M | Buy |
18,560
+300
| +2% | +$51.2K | 1.12% | 25 |
|
|
2021
Q2 | $3.01M | Hold |
18,260
| – | – | 1.09% | 25 |
|
|
2021
Q1 | $3M | Sell |
18,260
-25
| -0.1% | -$4.04K | 1.14% | 20 |
|
|
2020
Q4 | $2.88M | Sell |
18,285
-2,810
| -13% | -$415K | 1.28% | 16 |
|
|
2020
Q3 | $3.14M | Buy |
21,095
+3,435
| +19% | +$508K | 1.53% | 16 |
|
|
2020
Q2 | $3.13M | Sell |
17,660
-9,737
| -36% | -$1.42M | 1.78% | 13 |
|
|
2020
Q1 | $3.59M | Buy |
27,397
+9,145
| +50% | +$1.3M | 2.19% | 11 |
|
|
2019
Q4 | $2.66M | Buy |
18,252
+700
| +4% | +$94.9K | 1.22% | 21 |
|
|
2019
Q3 | $2.27M | Sell |
17,552
-2,590
| -13% | -$341K | 1.17% | 21 |
|
|
2019
Q2 | $2.81M | Sell |
20,142
-1,150
| -5% | -$159K | 1.35% | 21 |
|
|
2019
Q1 | $2.98M | Buy |
21,292
+11,928
| +127% | +$1.6M | 1.54% | 18 |
|
|
2018
Q4 | $1.21M | Sell |
9,364
-2,300
| -20% | -$321K | 0.73% | 39 |
|
|
2018
Q3 | $1.61M | Hold |
11,664
| – | – | 0.75% | 42 |
|
|
2018
Q2 | $1.42M | Buy |
11,664
+700
| +6% | +$87.3K | 0.7% | 41 |
|
|
2018
Q1 | $1.41M | Sell |
10,964
-770
| -7% | -$104K | 0.78% | 37 |
|
|
2017
Q4 | $1.64M | Hold |
11,734
| – | – | 0.8% | 39 |
|
|
2017
Q3 | $1.53M | Hold |
11,734
| – | – | 0.73% | 37 |
|
|
2017
Q2 | $1.55M | Sell |
11,734
-80
| -0.7% | -$10.2K | 0.71% | 38 |
|
|
2017
Q1 | $1.47M | Buy |
11,814
+602
| +5% | +$71.9K | 0.76% | 36 |
|
|
2016
Q4 | $1.29M | Sell |
11,212
-1,986
| -15% | -$229K | 0.7% | 37 |
|
|
2016
Q3 | $1.56M | Sell |
13,198
-300
| -2% | -$36.4K | 0.71% | 37 |
|
|
2016
Q2 | $1.64M | Hold |
13,498
| – | – | 0.8% | 34 |
|
|
2016
Q1 | $1.46M | Sell |
13,498
-30
| -0.2% | -$3.11K | 0.68% | 31 |
|
|
2015
Q4 | $1.39M | Sell |
13,528
-1,500
| -10% | -$151K | 0.61% | 31 |
|
|
2015
Q3 | $1.4M | Buy |
15,028
+410
| +3% | +$39.7K | 0.65% | 29 |
|
|
2015
Q2 | $1.43M | Sell |
14,618
-2,537
| -15% | -$254K | 0.56% | 33 |
|
|
2015
Q1 | $1.73M | Buy |
17,155
+17
| +0.1% | +$1.73K | 0.71% | 27 |
|
|
2014
Q4 | $1.79M | Sell |
17,138
-84
| -0.5% | -$8.85K | 0.71% | 26 |
|
|
2014
Q3 | $1.84M | Sell |
17,222
-73
| -0.4% | -$7.57K | 0.8% | 23 |
|
|
2014
Q2 | $1.81M | Sell |
17,295
-328
| -2% | -$33.2K | 0.71% | 23 |
|
|
2014
Q1 | $1.73M | Buy |
17,623
+316
| +2% | +$29.3K | 0.66% | 25 |
|
|
2013
Q4 | $1.58M | Sell |
17,307
-219
| -1% | -$20.2K | 0.61% | 28 |
|
|
2013
Q3 | $1.52M | Buy |
17,526
+697
| +4% | +$62.5K | 0.59% | 33 |
|
|
2013
Q2 | $1.46M | Buy |
+16,829
| New | +$1.43M | 0.61% | 29 |
|
Other funds holding JNJ
Cowen Prime Advisors's JNJ Position: Q2 2023 in Review
Cowen Prime Advisors reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2023, selling an estimated $74.2K and leaving 24,500 shares worth $4.06M. The position accounts for 1.4% of the portfolio, ranked #16.
Cowen Prime Advisors first reported a position in JNJ in Q2 2013 and has held it in 41 quarters since. The position peaked at $4.41M in Q4 2022. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.
- Cowen Prime Advisors held 24,500 shares of Johnson & Johnson worth $4.06M as of Q2 2023.
- Cowen Prime Advisors sold 460 Johnson & Johnson shares in Q2 2023, an estimated $74.2K.
- Johnson & Johnson made up 1.4% of Cowen Prime Advisors's portfolio in Q2 2023, its #16 holding.
- Cowen Prime Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 41 quarters since.
- Cowen Prime Advisors's Johnson & Johnson position peaked at $4.41M in Q4 2022.
- 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.